The Graduate School of Public Health is one of 17 schools at the University of Pittsburgh. The school, founded in 1948, was first led by Thomas Parran, surgeon general of the U.S. Public Health Service. It is ranked as the 13th best public health school in the United States by U.S. News & World Report.

During the past decade, Univ of Pittsburgh / Graduate School of Public Health conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univ of Pittsburgh / Graduate School of Public Health" #1 sponsor was "Glaxo Wellcome" with 1 trials, followed by "Hoffmann-La Roche" with 1 trials sponsored, "Merck Sharp & Dohme LLC" with 1 trials sponsored, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials sponsored and "University of Pittsburgh" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ of Pittsburgh / Graduate School of Public Health" #1 collaborator was "Hillman Foundation" with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "RK Mellon Foundation" with 1 trials as a collaborator and "The Pittsburgh Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Univ of Pittsburgh / Graduate School of Public Health" are "HIV Infections" (3 trials), "Cytomegalovirus Infections" (1 trials), "Gunshot Wound, Contact" (1 trials), "Hepatitis C" (1 trials) and "Herpes Simplex" (1 trials). Many other conditions were trialed in "Univ of Pittsburgh / Graduate School of Public Health" in a lesser frequency.

Most popular intervention types in "Univ of Pittsburgh / Graduate School of Public Health" are "Drug" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acyclovir" (1 trials), "Ganciclovir" (1 trials), "Indinavir sulfate" (1 trials), "Nelfinavir mesylate" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ of Pittsburgh / Graduate School of Public Health" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Univ of Pittsburgh / Graduate School of Public Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Univ of Pittsburgh / Graduate School of Public Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univ of Pittsburgh / Graduate School of Public Health, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".